Global Cyanocobalamin API Market Growth 2025-2031

Publication ID:

LPI08251740

Publication Date:

August 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cyanocobalamin API market size is predicted to grow from US$ 113 million in 2025 to US$ 149 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Cyanocobalamin is a synthetic form of Vitamin B12, used to treat and prevent Vitamin B12 deficiency. It's an API, meaning it's the active pharmaceutical ingredient in medications designed to address deficiencies and related conditions like anemia and nerve damage.
锘緾yanocobalamin API, the classic form of vitamin B12, is vital in clinical applications, especially for treating megaloblastic anemia and maintaining neurological function, due to its stable chemical structure and well - defined biological activity. It also serves as a key component in nutritional fortifiers, dietary supplements, and specialized medical products.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淐yanocobalamin API Industry Forecast鈥� looks at past sales and reviews total world Cyanocobalamin API sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyanocobalamin API sales for 2025 through 2031. With Cyanocobalamin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyanocobalamin API industry.
This Insight Report provides a comprehensive analysis of the global Cyanocobalamin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyanocobalamin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cyanocobalamin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyanocobalamin API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyanocobalamin API.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 鈮�99%
Purity <99%
Segmentation by Application:
Oral Formulation
Injectable Formulation
Sprays
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
Ningxia Kingvit Pharmaceutical
North China Pharmaceutical Company
EUROAPI
HTBA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cyanocobalamin API market?
What factors are driving Cyanocobalamin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyanocobalamin API market opportunities vary by end market size?
How does Cyanocobalamin API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cyanocobalamin API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cyanocobalamin API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cyanocobalamin API by Country/Region, 2020, 2024 & 2031
2.2 Cyanocobalamin API Segment by Type
2.2.1 Purity 鈮�99%
2.2.2 Purity <99%
2.3 Cyanocobalamin API Sales by Type
2.3.1 Global Cyanocobalamin API Sales Market Share by Type (2020-2025)
2.3.2 Global Cyanocobalamin API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cyanocobalamin API Sale Price by Type (2020-2025)
2.4 Cyanocobalamin API Segment by Application
2.4.1 Oral Formulation
2.4.2 Injectable Formulation
2.4.3 Sprays
2.5 Cyanocobalamin API Sales by Application
2.5.1 Global Cyanocobalamin API Sale Market Share by Application (2020-2025)
2.5.2 Global Cyanocobalamin API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cyanocobalamin API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Cyanocobalamin API Breakdown Data by Company
3.1.1 Global Cyanocobalamin API Annual Sales by Company (2020-2025)
3.1.2 Global Cyanocobalamin API Sales Market Share by Company (2020-2025)
3.2 Global Cyanocobalamin API Annual Revenue by Company (2020-2025)
3.2.1 Global Cyanocobalamin API Revenue by Company (2020-2025)
3.2.2 Global Cyanocobalamin API Revenue Market Share by Company (2020-2025)
3.3 Global Cyanocobalamin API Sale Price by Company
3.4 Key Manufacturers Cyanocobalamin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyanocobalamin API Product Location Distribution
3.4.2 Players Cyanocobalamin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Cyanocobalamin API by Geographic Region
4.1 World Historic Cyanocobalamin API Market Size by Geographic Region (2020-2025)
4.1.1 Global Cyanocobalamin API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cyanocobalamin API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cyanocobalamin API Market Size by Country/Region (2020-2025)
4.2.1 Global Cyanocobalamin API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cyanocobalamin API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyanocobalamin API Sales Growth
4.4 APAC Cyanocobalamin API Sales Growth
4.5 Europe Cyanocobalamin API Sales Growth
4.6 Middle East & Africa Cyanocobalamin API Sales Growth
5 Americas
5.1 Americas Cyanocobalamin API Sales by Country
5.1.1 Americas Cyanocobalamin API Sales by Country (2020-2025)
5.1.2 Americas Cyanocobalamin API Revenue by Country (2020-2025)
5.2 Americas Cyanocobalamin API Sales by Type (2020-2025)
5.3 Americas Cyanocobalamin API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyanocobalamin API Sales by Region
6.1.1 APAC Cyanocobalamin API Sales by Region (2020-2025)
6.1.2 APAC Cyanocobalamin API Revenue by Region (2020-2025)
6.2 APAC Cyanocobalamin API Sales by Type (2020-2025)
6.3 APAC Cyanocobalamin API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cyanocobalamin API by Country
7.1.1 Europe Cyanocobalamin API Sales by Country (2020-2025)
7.1.2 Europe Cyanocobalamin API Revenue by Country (2020-2025)
7.2 Europe Cyanocobalamin API Sales by Type (2020-2025)
7.3 Europe Cyanocobalamin API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cyanocobalamin API by Country
8.1.1 Middle East & Africa Cyanocobalamin API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cyanocobalamin API Revenue by Country (2020-2025)
8.2 Middle East & Africa Cyanocobalamin API Sales by Type (2020-2025)
8.3 Middle East & Africa Cyanocobalamin API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyanocobalamin API
10.3 Manufacturing Process Analysis of Cyanocobalamin API
10.4 Industry Chain Structure of Cyanocobalamin API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyanocobalamin API Distributors
11.3 Cyanocobalamin API Customer
12 World Forecast Review for Cyanocobalamin API by Geographic Region
12.1 Global Cyanocobalamin API Market Size Forecast by Region
12.1.1 Global Cyanocobalamin API Forecast by Region (2026-2031)
12.1.2 Global Cyanocobalamin API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cyanocobalamin API Forecast by Type (2026-2031)
12.7 Global Cyanocobalamin API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Hebei Yuxing Bio-Engineering
13.1.1 Hebei Yuxing Bio-Engineering Company Information
13.1.2 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolios and Specifications
13.1.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hebei Yuxing Bio-Engineering Main Business Overview
13.1.5 Hebei Yuxing Bio-Engineering Latest Developments
13.2 Hebei Huarong Pharmaceutical
13.2.1 Hebei Huarong Pharmaceutical Company Information
13.2.2 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolios and Specifications
13.2.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hebei Huarong Pharmaceutical Main Business Overview
13.2.5 Hebei Huarong Pharmaceutical Latest Developments
13.3 Ningxia Kingvit Pharmaceutical
13.3.1 Ningxia Kingvit Pharmaceutical Company Information
13.3.2 Ningxia Kingvit Pharmaceutical Cyanocobalamin API Product Portfolios and Specifications
13.3.3 Ningxia Kingvit Pharmaceutical Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Ningxia Kingvit Pharmaceutical Main Business Overview
13.3.5 Ningxia Kingvit Pharmaceutical Latest Developments
13.4 North China Pharmaceutical Company
13.4.1 North China Pharmaceutical Company Company Information
13.4.2 North China Pharmaceutical Company Cyanocobalamin API Product Portfolios and Specifications
13.4.3 North China Pharmaceutical Company Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 North China Pharmaceutical Company Main Business Overview
13.4.5 North China Pharmaceutical Company Latest Developments
13.5 EUROAPI
13.5.1 EUROAPI Company Information
13.5.2 EUROAPI Cyanocobalamin API Product Portfolios and Specifications
13.5.3 EUROAPI Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 EUROAPI Main Business Overview
13.5.5 EUROAPI Latest Developments
13.6 HTBA
13.6.1 HTBA Company Information
13.6.2 HTBA Cyanocobalamin API Product Portfolios and Specifications
13.6.3 HTBA Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HTBA Main Business Overview
13.6.5 HTBA Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂